Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy) piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein
AssigneeHanmi Science Co., Ltd.
InventorsKeuk Chan Bang, Young Ho Moon, Young Kil Chang
Life of this patent
Estimating the term…
Abstract
The present invention relates to an improved method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride, which selectively and effectively inhibits the growth of cancer cells induced by over-expression of an epidermal growth factor receptor (EGFR) and prevents the development of drug resistance caused by mutation of a tyrosine kinase, and intermediates used therein.
Claims18
A method for preparing a 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride of formula (I), which comprises the steps of:
- (1) subjecting a compound of formula (VIII) to a reaction with a halogenating agent in the presence of an organic base, followed by a reaction with a compound of formula (X), to produce a compound of formula (VI);
- (2) subjecting the compound of formula (VI) to a reaction with an ammonia solution in a polar protic solvent to produce a compound of formula (V);
- (3) subjecting the compound of formula (V) to a reaction with a compound of formula (IX) in an inert polar protic solvent in the presence of a base to produce a compound of formula (IV);
- (4) subjecting the compound of formula (IV) to a reaction with hydrochloric acid in an inert solvent to produce a compound of formula (III);
- (5) subjecting the compound of formula (III) to an acrylation reaction with
- (wherein X is halogen) in the presence of a base to produce a compound of formula (II);
- and
- (6) subjecting the compound of formula (II) to a reaction with hydrochloric acid to produce the compound of formula (I):
N-(3,4-dichloro-2-fluorophenyl)-7-methoxy-6-(piperidin-4-yloxy)quinazolin-4-amine dihydrochloride of formula (III):
tert-butyl 4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-carboxylate of formula (IV):
4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-ol of formula (V):
Dependencies are inferred from the claim text.